Stay updated with breaking news from Lupus Sci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosusSaphnelo is a first-in-class type I interferon receptor antibody and the only new medicine in over a decade for patients with systemic lupus erythematosusAstraZeneca’s Saphnelo (anifrolumab) has been approved in the...
/PRNewswire/ -- Pediatric lupus expert Virginia Pascual, MD together with her junior colleague Simone Caielli, PhD and their team at Weill Cornell Medicine in...
/PRNewswire/ -- Pediatric lupus expert Virginia Pascual, MD together with her junior colleague Simone Caielli, PhD and their team at Weill Cornell Medicine in...
Press release content from PR Newswire. The AP news staff was not involved in its creation.